[KRAS mutations and survival after resection of colorectal liver metastases]

Chirurg. 2015 Nov;86(11):1071. doi: 10.1007/s00104-015-0092-y.

[Article in German]

Authors

P Mroczkowski¹, C J Bruns²

Affiliations

¹ Klinik für Allgemein-, Viszeral- und Gefäßchirurgie, Otto-von-Guericke-Universität Magdeburg, Leipziger Straße 44, 39120, Magdeburg, Deutschland. [email protected].
² Klinik für Allgemein-, Viszeral- und Gefäßchirurgie, Otto-von-Guericke-Universität Magdeburg, Leipziger Straße 44, 39120, Magdeburg, Deutschland.

PMID: 26428229
DOI: 10.1007/s00104-015-0092-y

No abstract available

Publication types

Meta-Analysis

MeSH terms

Colorectal Neoplasms / genetics*
Colorectal Neoplasms / mortality
Colorectal Neoplasms / surgery*
DNA Mutational Analysis*
Humans
Liver Neoplasms / genetics*
Liver Neoplasms / mortality
Liver Neoplasms / secondary*
Liver Neoplasms / surgery*
Prognosis
Proto-Oncogene Proteins p21(ras) / genetics*
Survival Rate

Substances

KRAS protein, human
Proto-Oncogene Proteins p21(ras)